424 filings
Page 6 of 22
6-K
t7tq4zo scy3al
8 Oct 20
Biofrontera AG reports completion of the clinical phase of the pharmacokinetics study
11:42am
6-K
qq4tjluo70mdcxt
23 Sep 20
Current report (foreign)
6:15am
6-K
ebw7g14ekhxly7y8
21 Sep 20
Managers’ transactions announcement according to article 19 MAR
3:52pm
6-K
dmqzd7
21 Sep 20
Managers’ transactions announcement according to article 19 MAR
3:50pm
6-K
a1n28 4rp9y2hij1h
21 Sep 20
Managers’ transactions announcement according to article 19 MAR
3:47pm
6-K
kfmxwgca
11 Sep 20
Current report (foreign)
7:59am
6-K
i14utol321k6ks43
9 Sep 20
Biofrontera AG to participate in two upcoming conferences
9:35am
6-K
4wiky85 kgja
28 Aug 20
Announcement of the adjustment of the conversion price
6:15am
6-K
fmt28uvdna
27 Aug 20
Biofrontera report results for the first six months of 2020
6:15am
6-K
du6bu4ik2b3j
25 Aug 20
Current report (foreign)
10:51am
6-K
zqhskpji 614nizuqz2
25 Aug 20
Current report (foreign)
10:49am
6-K
7f26pjofqbkrn g6
21 Aug 20
Admission to trading of Biofrontera’s 1.00% qualified subordinated mandatory convertible bond 2020/2021
6:10am
6-K
3lcn62nt1 d5vh2
19 Aug 20
Current report (foreign)
6:20am
6-K
989xv
19 Aug 20
Current report (foreign)
6:15am
6-K
j5fv udf4
18 Aug 20
Current report (foreign)
6:05am
6-K
muc4fjeks fm0
14 Aug 20
Result of the subscription of the 1.00 % qualified subordinated mandatory convertible bond 2020/2021
6:14am
6-K
ady8xxm9shwi
12 Aug 20
Managers’ transactions announcement according to article 19 MAR
5:04pm
6-K
3k0hmqtbzlescu8 w9s
12 Aug 20
Managers’ transactions announcement according to article 19 MAR
5:02pm
6-K
sz3d18pbgra oj84n
12 Aug 20
Managers’ transactions announcement according to article 19 MAR
5:01pm
6-K
jsfj0
10 Aug 20
Current report (foreign)
1:50pm